South Korea’s GC Pharma Group has decided to sell two of its North American subsidiaries - a plasma fractionation facility in Canada and a US-based plasma collection organization - to Spain's Grifols, S.A. for $460m, in its first large-scale sale of overseas assets in a package deal expected to close by the end of the year.
The divestment includes GC Biotherapeutics Inc